LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 27.84 | 770.25 | 1526 | 2833 | 0.5385 | 0.4388 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 30.06 | 770.25 | 1587 | 3106 | 0.5109 | 0.4324 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 30.06 | 770.25 | 1564 | 3106 | 0.5035 | 0.4220 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 32.28 | 770.25 | 1620 | 3392 | 0.4775 | 0.4156 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 32.28 | 770.25 | 1565 | 3392 | 0.4613 | 0.3929 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 34.50 | 770.25 | 1630 | 3712 | 0.4391 | 0.3915 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 34.50 | 770.25 | 1589 | 3712 | 0.4281 | 0.3760 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 36.73 | 770.25 | 1653 | 4086 | 0.4045 | 0.3733 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 36.73 | 770.25 | 1601 | 4086 | 0.3918 | 0.3552 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 38.95 | 770.25 | 1652 | 4543 | 0.3636 | 0.3472 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 38.95 | 770.25 | 1610 | 4543 | 0.3543 | 0.3337 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 41.17 | 770.25 | 1687 | 5010 | 0.3367 | 0.3367 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 41.17 | 770.25 | 1651 | 5010 | 0.3295 | 0.3261 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 43.39 | 770.25 | 1729 | 5404 | 0.3199 | 0.3333 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 43.39 | 770.25 | 1690 | 5404 | 0.3127 | 0.3226 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 45.61 | 770.25 | 1764 | 5813 | 0.3035 | 0.3287 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 45.61 | 770.25 | 1785 | 5813 | 0.3071 | 0.3341 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 47.83 | 770.25 | 1858 | 6223 | 0.2986 | 0.3393 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 47.83 | 770.25 | 1831 | 6223 | 0.2942 | 0.3328 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 50.05 | 770.25 | 1904 | 6629 | 0.2872 | 0.3383 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 50.05 | 770.25 | 1907 | 6629 | 0.2877 | 0.3390 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 52.27 | 770.25 | 2022 | 7058 | 0.2865 | 0.3525 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 52.27 | 770.25 | 1996 | 7058 | 0.2828 | 0.3471 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 54.49 | 770.25 | 2101 | 7555 | 0.2781 | 0.3561 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 54.49 | 770.25 | 2070 | 7555 | 0.2740 | 0.3500 | MN20160304_L02 | I05 |